251 related articles for article (PubMed ID: 25583716)
1. The strength of synergistic interaction between posaconazole and caspofungin depends on the underlying azole resistance mechanism of Aspergillus fumigatus.
Mavridou E; Meletiadis J; Rijs A; Mouton JW; Verweij PE
Antimicrob Agents Chemother; 2015 Mar; 59(3):1738-44. PubMed ID: 25583716
[TBL] [Abstract][Full Text] [Related]
2. In vitro interaction of voriconazole and anidulafungin against triazole-resistant Aspergillus fumigatus.
Seyedmousavi S; Meletiadis J; Melchers WJ; Rijs AJ; Mouton JW; Verweij PE
Antimicrob Agents Chemother; 2013 Feb; 57(2):796-803. PubMed ID: 23183435
[TBL] [Abstract][Full Text] [Related]
3. In vitro efficacy of the combination of voriconazole and anidulafungin against voriconazole-resistant cyp51A mutants of Aspergillus fumigatus.
Krishnan-Natesan S; Wu W; Chandrasekar PH
Diagn Microbiol Infect Dis; 2012 Jun; 73(2):135-7. PubMed ID: 22608136
[TBL] [Abstract][Full Text] [Related]
4. In-vitro activity of nikkomycin Z alone and in combination with polyenes, triazoles or echinocandins against Aspergillus fumigatus.
Ganesan LT; Manavathu EK; Cutright JL; Alangaden GJ; Chandrasekar PH
Clin Microbiol Infect; 2004 Nov; 10(11):961-6. PubMed ID: 15521997
[TBL] [Abstract][Full Text] [Related]
5. Azole, polyene and echinocandin MIC distributions for wild-type, TR34/L98H and TR46/Y121F/T289A Aspergillus fumigatus isolates in the Netherlands.
van Ingen J; van der Lee HA; Rijs TA; Zoll J; Leenstra T; Melchers WJ; Verweij PE
J Antimicrob Chemother; 2015 Jan; 70(1):178-81. PubMed ID: 25301884
[TBL] [Abstract][Full Text] [Related]
6. Rezafungin (CD101) demonstrates potent in vitro activity against Aspergillus, including azole-resistant Aspergillus fumigatus isolates and cryptic species.
Wiederhold NP; Locke JB; Daruwala P; Bartizal K
J Antimicrob Chemother; 2018 Nov; 73(11):3063-3067. PubMed ID: 30032217
[TBL] [Abstract][Full Text] [Related]
7. Impact of in vivo triazole and echinocandin combination therapy for invasive pulmonary aspergillosis: enhanced efficacy against Cyp51 mutant isolates.
Lepak AJ; Marchillo K; VanHecker J; Andes DR
Antimicrob Agents Chemother; 2013 Nov; 57(11):5438-47. PubMed ID: 23959322
[TBL] [Abstract][Full Text] [Related]
8. Differential activity of triazoles in two-drug combinations with the echinocandin caspofungin against Aspergillus fumigatus.
Manavathu EK; Alangaden GJ; Chandrasekar PH
J Antimicrob Chemother; 2003 Jun; 51(6):1423-5. PubMed ID: 12716776
[TBL] [Abstract][Full Text] [Related]
9. The evaluation of in vitro pharmacodynamic properties of amphotericin B, voriconazole and caspofungin against A. fumigatus isolates by the conventional and colorimetric time-kill assays.
Kiraz N; Oz Y; Dag I
Med Mycol; 2011 Aug; 49(6):594-601. PubMed ID: 21299374
[TBL] [Abstract][Full Text] [Related]
10. Combined activity in vitro of caspofungin, amphotericin B, and azole agents against itraconazole-resistant clinical isolates of Aspergillus fumigatus.
Cuenca-Estrella M; Gomez-Lopez A; Garcia-Effron G; Alcazar-Fuoli L; Mellado E; Buitrago MJ; Rodriguez-Tudela JL
Antimicrob Agents Chemother; 2005 Mar; 49(3):1232-5. PubMed ID: 15728937
[TBL] [Abstract][Full Text] [Related]
11. Azole antifungal resistance in Aspergillus fumigatus: 2008 and 2009.
Bueid A; Howard SJ; Moore CB; Richardson MD; Harrison E; Bowyer P; Denning DW
J Antimicrob Chemother; 2010 Oct; 65(10):2116-8. PubMed ID: 20729241
[TBL] [Abstract][Full Text] [Related]
12. Establishing in vitro-in vivo correlations for Aspergillus fumigatus: the challenge of azoles versus echinocandins.
Arendrup MC; Perkhofer S; Howard SJ; Garcia-Effron G; Vishukumar A; Perlin D; Lass-Flörl C
Antimicrob Agents Chemother; 2008 Oct; 52(10):3504-11. PubMed ID: 18644959
[TBL] [Abstract][Full Text] [Related]
13. Genotype-phenotype complexity of the TR46/Y121F/T289A cyp51A azole resistance mechanism in Aspergillus fumigatus.
Snelders E; Camps SM; Karawajczyk A; Rijs AJ; Zoll J; Verweij PE; Melchers WJ
Fungal Genet Biol; 2015 Sep; 82():129-35. PubMed ID: 26092193
[TBL] [Abstract][Full Text] [Related]
14. In vitro interaction of isavuconazole and anidulafungin against azole-susceptible and azole-resistant Aspergillus fumigatus isolates.
Buil JB; Brüggemann RJM; Bedin Denardi L; Melchers WJG; Verweij PE
J Antimicrob Chemother; 2020 Sep; 75(9):2582-2586. PubMed ID: 32516368
[TBL] [Abstract][Full Text] [Related]
15. Acquired antifungal drug resistance in Aspergillus fumigatus: epidemiology and detection.
Howard SJ; Arendrup MC
Med Mycol; 2011 Apr; 49 Suppl 1():S90-5. PubMed ID: 20795765
[TBL] [Abstract][Full Text] [Related]
16. High prevalence of azole resistance in Aspergillus fumigatus isolates from high-risk patients.
Fuhren J; Voskuil WS; Boel CH; Haas PJ; Hagen F; Meis JF; Kusters JG
J Antimicrob Chemother; 2015 Oct; 70(10):2894-8. PubMed ID: 26163402
[TBL] [Abstract][Full Text] [Related]
17. cyp51A-based mechanism of azole resistance in Aspergillus fumigatus: Illustration by a new 3D Structural Model of Aspergillus fumigatus CYP51A protein.
Liu M; Zheng N; Li D; Zheng H; Zhang L; Ge H; Liu W
Med Mycol; 2016 May; 54(4):400-8. PubMed ID: 26768370
[TBL] [Abstract][Full Text] [Related]
18. Isolation of multiple-triazole-resistant Aspergillus fumigatus strains carrying the TR/L98H mutations in the cyp51A gene in India.
Chowdhary A; Kathuria S; Randhawa HS; Gaur SN; Klaassen CH; Meis JF
J Antimicrob Chemother; 2012 Feb; 67(2):362-6. PubMed ID: 22028200
[TBL] [Abstract][Full Text] [Related]
19. Low prevalence of resistance to azoles in Aspergillus fumigatus in a French cohort of patients treated for haematological malignancies.
Alanio A; Sitterlé E; Liance M; Farrugia C; Foulet F; Botterel F; Hicheri Y; Cordonnier C; Costa JM; Bretagne S
J Antimicrob Chemother; 2011 Feb; 66(2):371-4. PubMed ID: 21131690
[TBL] [Abstract][Full Text] [Related]
20. First determination of azole resistance in Aspergillus fumigatus strains carrying the TR34/L98H mutations in Turkey.
Özmerdiven GE; Ak S; Ener B; Ağca H; Cilo BD; Tunca B; Akalın H
J Infect Chemother; 2015 Aug; 21(8):581-6. PubMed ID: 26048062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
